BMC Gastroenterology (Jul 2023)

Gut microbiota analyses of inflammatory bowel diseases from a representative Saudi population

  • Raed M. Alsulaiman,
  • Abdulaziz A. Al-Quorain,
  • Fahad A. Al-Muhanna,
  • Stanley Piotrowski,
  • Ezzeddin A. Kurdi,
  • Chittibabu Vatte,
  • Ahmed A. Alquorain,
  • Noorah H. Alfaraj,
  • Abdulaziz M. Alrezuk,
  • Fred Robinson,
  • Alexa K. Dowdell,
  • Turki A. Alamri,
  • Lauren Hamilton,
  • Hetal Lad,
  • Hui Gao,
  • Divya Gandla,
  • Brendan J. Keating,
  • Ryan Meng,
  • Brian Piening,
  • Amein K. Al-Ali

DOI
https://doi.org/10.1186/s12876-023-02904-2
Journal volume & issue
Vol. 23, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Background Crohn’s diseases and ulcerative colitis, both of which are chronic immune-mediated disorders of the gastrointestinal tract are major contributors to the overarching Inflammatory bowel diseases. It has become increasingly evident that the pathological processes of IBDs results from interactions between genetic and environmental factors, which can skew immune responses against normal intestinal flora. Methods The aim of this study is to assess and analyze the taxa diversity and relative abundances in CD and UC in the Saudi population. We utilized a sequencing strategy that targets all variable regions in the 16 S rRNA gene using the Swift Amplicon 16 S rRNA Panel on Illumina NovaSeq 6000. Results The composition of stool 16 S rRNA was analyzed from 219 patients with inflammatory bowel disease and from 124 healthy controls. We quantified the abundance of microbial communities to examine any significant differences between subpopulations of samples. At the genus level, two genera in particular, Veillonella and Lachnoclostridium showed significant association with CD versus controls. There were significant differences between subjects with CD versus UC, with the top differential genera spanning Akkermansia, Harryflintia, Maegamonas and Phascolarctobacterium. Furthermore, statistically significant taxa diversity in microbiome composition was observed within the UC and CD groups. Conclusions In conclusion we have shown that there are significant differences in gut microbiota between UC, CD and controls in a Saudi Arabian inflammatory bowel disease cohort. This reinforces the need for further studies in large populations that are ethnically and geographically diverse. In addition, our results show the potential to develop classifiers that may have add additional richness of context to clinical diagnosis of UC and CD with larger inflammatory bowel disease cohorts.

Keywords